These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6367164)

  • 1. Successful removal and prevention of resynthesis of anti-HLA antibody.
    Taube DH; Welsh KI; Kennedy LA; Thick MG; Bewick M; Cameron JS; Ogg CS; Rudge CJ; Williams DG
    Transplantation; 1984 Mar; 37(3):254-5. PubMed ID: 6367164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
    Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
    Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C
    Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplantation after removal and prevention of resynthesis of HLA antibodies.
    Taube DH; Williams DG; Cameron JS; Bewick M; Ogg CS; Rudge CJ; Welsh KI; Kennedy LA; Thick MG
    Lancet; 1984 Apr; 1(8381):824-8. PubMed ID: 6143141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.
    Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W
    J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmapheresis, immunosuppressive therapy and kidney transplant in a pre-sensitized patient].
    Cuéllar-Cabrera H; Ramírez-Fernández M; Guerra-Rosales MJ; Sánchez-Avila MA
    Bol Med Hosp Infant Mex; 1989 Apr; 46(4):246-50. PubMed ID: 2655653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Immunoglobulin and Rituximab in HLA Highly Sensitized Kidney Transplant Recipients.
    Querido S; Weigert A; Adragão T; Henriques J; Birne R; Matias P; Jorge C; Nascimento C; Bruges M; Machado D
    Transplant Proc; 2018 Apr; 50(3):723-727. PubMed ID: 29661424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.
    Opelz G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1570-6. PubMed ID: 15866311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidden perils in a highly sensitized kidney transplant recipient.
    Ford S; Summers S; Cantwell L; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
    Radvany RM; Patel KM
    Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined liver and kidney transplantation in a highly sensitized and positively cross-matched patient.
    Alqurashi S; Alsayyari AA; Abdullah K; Alwan A; Hajeer AH
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):757-60. PubMed ID: 21743223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in HLA-immunosensitized patients prior to kidney transplantation.
    Alarabi A; Backman U; Wikström B; Sjöberg O; Tufveson G
    Int J Artif Organs; 1997 Jan; 20(1):51-6. PubMed ID: 9062832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.